JNJ NYSE
Johnson & Johnson
1W: -5.6%
1M: -6.9%
3M: -1.2%
YTD: +24.2%
1Y: +38.5%
3Y: +74.7%
5Y: +76.3%
$256.03
-2.63 (-1.02%)
Weekly Expected Move ±2.0%
$246
$251
$256
$261
$266
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider—
Congress5 trades
ETF Holdings—
Key Statistics
Market Cap$617.0B
52W Range146.12-281.07
Volume10,176,696
Avg Volume7,484,338
Beta0.23
Dividend$5.28
Analyst Ratings
Company Info
CEOJoaquin Duato
Employees141,700
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1962-01-02
Websitejnj.com
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
US
New Brunswick, NJ 08933
US
732 524 0400
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Latest News
The Stock Market Just Flashed a Warning Signal Seen Only Twice in 155 Years. Here Are 3 Stocks That Can Weather What History Says Comes Next.
Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma
3 of the Best ETFs to Buy and Hold if a Recession Is Coming
Most and least shorted mid- to mega-cap healthcare stocks at the end of September
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Pinto Daniel E | A-Award | 113 | — | 2026-09-08 |
| Woods Eugene A. | A-Award | 136 | — | 2026-09-08 |
| HEWSON MARILLYN A | A-Award | 181 | — | 2026-09-08 |
| Schmid Timothy | M-Exempt | 11,070 | $131.94 | 2026-09-02 |
| Schmid Timothy | S-Sale | 22,527 | $274.74 | 2026-09-02 |